APA (7th ed.) Citation

A, H., PEM, P., A, K., ML, O., B, H., & R, S. (2021). Colitis After CAR T-Cell Therapy for Refractory Large B-Cell Lymphoma Responds to Anti-Integrin Therapy. Inflammatory bowel diseases, 27(4), e45. https://doi.org/10.1093/ibd/izaa320

Chicago Style (17th ed.) Citation

A, Hashim, Patten PEM, Kuhnl A, Ooft ML, Hayee B, and Sanderson R. "Colitis After CAR T-Cell Therapy for Refractory Large B-Cell Lymphoma Responds to Anti-Integrin Therapy." Inflammatory Bowel Diseases 27, no. 4 (2021): e45. https://doi.org/10.1093/ibd/izaa320.

MLA (9th ed.) Citation

A, Hashim, et al. "Colitis After CAR T-Cell Therapy for Refractory Large B-Cell Lymphoma Responds to Anti-Integrin Therapy." Inflammatory Bowel Diseases, vol. 27, no. 4, 2021, p. e45, https://doi.org/10.1093/ibd/izaa320.